Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.18 USD | -6.70% | -10.26% | +29.63% |
20/03 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
19/03 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.63% | 352M | |
+18.53% | 47.02B | |
+48.77% | 41.86B | |
+0.42% | 41.76B | |
-4.27% | 28.8B | |
+11.77% | 26.05B | |
-22.06% | 19.15B | |
+4.55% | 12.55B | |
+29.84% | 12.34B | |
-3.95% | 11.82B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Tenaya Therapeutics : Morgan Stanley Initiates Coverage on Tenaya Therapeutics With Overweight Rating, $31 Price Target